|
7/28/15
|
CardioKinetix Inc agreed to a five-year lease for 14.1k sf of office and lab space in Menlo Park. The firm’s new space is located at 1360 O’Brien Dr, south of Bayfront Expwy and west of University Ave, within Tarlton Properties Inc’s Menlo Business Park.
CardioKinetix, a Menlo-based medical device company pioneering a catheter-based treatment for heart failure, has developed a transcatheter implant called the Parachute® Ventricular Partitioning Device (Parachute), which intends to treat heart failure resulting from a heart attack in patients worldwide by improving overall cardiac function.
This new lease at Menlo Business Park comes on the heels of a 31k sf lease by Personalis Inc, a leading genomics-based clinical diagnostic laboratory; and an 18k sf, long-term lease expansion by Intersect ENT Inc, an ear, nose and throat biotech company.
Kidder Mathews represented Tarlton Properties and Jones Lang LaSalle represented CardioKinetix in the transaction. The lease value was not disclosed.
|
|
Return to the Archive page
|
|
|
|
|